Taken together, the abnormal molecular phenotype seen with reduced Shroom3 expression at 3 months may contribute to increased sensitivity to kidney disease and worsened tubular repair and glomerular disease after a kidney insult or with aging. Here, SHROOM3 is linked to glomerular disorder.